Omics in medicine: current applications and prospects, with a focus on cytopenias

Blood cytopenias are common and pose problems for diagnosis and treatment. The advent of new technologies—molecular biology, artificial intelligence, big data, predictive and preventive medicine, telemedicine—is profoundly transforming our understanding, diagnosis, and management of these conditions. Molecular biology makes it possible to identify distinct immunogenetic subtypes. Predictive medicine anticipates the risks of progression and relapse. Preventive medicine aims to limit complications and hospitalizations. Artificial intelligence assists clinicians in diagnosis and therapeutic decision-making. Big data enriches knowledge of the disease in real life, and telemedicine ensures personalized remote monitoring. This technological convergence paves the way for personalized, integrated, and efficient medicine for patients with ITP.